Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Quisette Janssen, Stefan Buettner, Mustafa Suker, Georgios A Margonis, Alessandro Paniccia, Bassel F. El-Rayes, Nathan Bahary, Ian Chau, Peter Joel Hosein, Andrew H. Ko, Jill Lacy, Nigel Jamieson, Christoph Tinchon, Kyu-Pyo Kim, Marc G. Besselink, Johanna Wilmink, Marjolein Y.V. Homs, Casper H.J. van Eijck, Matthew H. G. Katz, Bas Groot Koerkamp
Institutions: Erasmus MC, Erasmus MC Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Emory University, Winship Cancer Institute, University of Pittsburgh Medical Center, Royal Marsden Hospital, University of Miami, Sylvester Comprehensive Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Yale University, Smilow Cancer Hospital, Glasgow Royal Infirmary, LKH Hochsteiermark, Asan Medical Center, University of Ulsan, Amsterdam UMC Location University of Amsterdam, Cancer Center Amsterdam, University of Amsterdam, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: ZonMw
Award: G3174008395
OpenAlex ID: W2890769054